These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8701300)
1. Chemoprevention of cancer. Greenwald P Sci Am; 1996 Sep; 275(3):96-9. PubMed ID: 8701300 [No Abstract] [Full Text] [Related]
2. Allium vegetables and the potential for chemoprevention of cancer. Wargovich MJ; Uda N Adv Exp Med Biol; 1996; 401():171-7. PubMed ID: 8886135 [No Abstract] [Full Text] [Related]
3. New opportunities in chemoprevention research. Kucuk O Cancer Invest; 2002; 20(2):237-45. PubMed ID: 11901544 [TBL] [Abstract][Full Text] [Related]
4. Cancer chemoprevention by polyphenols in green tea and artichoke. Agarwal R; Mukhtar H Adv Exp Med Biol; 1996; 401():35-50. PubMed ID: 8886125 [No Abstract] [Full Text] [Related]
5. Chemoprevention of human cancer: a reasonable strategy? Meyskens FL Recent Results Cancer Res; 1999; 151():113-21. PubMed ID: 10337722 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention clinical trials: it is time to turn success into progress. Brown PH Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1531-2. PubMed ID: 17684123 [No Abstract] [Full Text] [Related]
7. Second international cancer chemoprevention conference. Benner SE; Pastorino U; Lippman SM; Hong WK Cancer Res; 1994 Feb; 54(3):854-6. PubMed ID: 7905788 [No Abstract] [Full Text] [Related]
8. Cancer chemoprevention. Greenwald P BMJ; 2002 Mar; 324(7339):714-8. PubMed ID: 11909790 [No Abstract] [Full Text] [Related]
9. Current strategies of cancer chemoprevention: 13th Sapporo cancer seminar. Boone CW; Wattenberg LW Cancer Res; 1994 Jun; 54(12):3315-8. PubMed ID: 7911397 [No Abstract] [Full Text] [Related]
10. Is chemoprevention overrated or underfunded? Nelson NJ J Natl Cancer Inst; 1996 Jul; 88(14):947-9. PubMed ID: 8667423 [No Abstract] [Full Text] [Related]
11. Cancer prevention. Osborne M; Boyle P; Lipkin M Lancet; 1997 May; 349 Suppl 2():SII27-30. PubMed ID: 9164445 [No Abstract] [Full Text] [Related]
13. General keynote: the impact of cancer chemoprevention. Hong WK Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S56-8. PubMed ID: 12586087 [No Abstract] [Full Text] [Related]
14. [Chemoprevention of cancers]. Espie M Bull Cancer; 1995 Jul; 82 Suppl 3():181s-185s. PubMed ID: 7492832 [TBL] [Abstract][Full Text] [Related]
15. Participant enrollment, participation, and compliance in chemoprevention trials. Rimer BK Adv Exp Med Biol; 1992; 320():111-7. PubMed ID: 1442275 [TBL] [Abstract][Full Text] [Related]
16. Patient participation and compliance in cancer chemoprevention trials: issues and concerns. Tangrea JA Proc Soc Exp Biol Med; 1997 Nov; 216(2):260-5. PubMed ID: 9349695 [TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of cancer for the next millennium--quo vadis? Zänker KS Cancer Lett; 1999 Sep; 143 Suppl 1():S7-11. PubMed ID: 10546590 [No Abstract] [Full Text] [Related]
18. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331 [TBL] [Abstract][Full Text] [Related]
19. How should we move the field of chemopreventive agent development forward in a productive manner? Meyskens FL; Szabo E Recent Results Cancer Res; 2005; 166():113-24. PubMed ID: 15648187 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in chemoprevention of cancer. Hong WK; Sporn MB Science; 1997 Nov; 278(5340):1073-7. PubMed ID: 9353183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]